Reflux Esophagitis Drugs Worsen Outcomes for COVID-19 Patients

SEOUL, Aug. 3 (Korea Bizwire) — A recent study has found that proton pump inhibitors (PPIs), the drugs commonly used in the treatment of reflux esophagitis, can increase the risk of COVID-19 patients suffering more severe illness by up to 79 percent. A research team consisting of professors at Cha University Graduate School of Medicine [...]